Our Products
Coffmul®LS
Product Composition
Packaging Details
Product Description
COFFMUL LS Syrup – Complete Product Information
1. Product Overview
COFFMUL LS Syrup by Amcare Pharmaceuticals is a combination oral respiratory formulation containing Levosalbutamol Sulphate, Ambroxol Hydrochloride and Guaiphenesin.
According to the supplied product artwork, each 5 mL contains:
-
Levosalbutamol Sulphate IP – equivalent to Levosalbutamol 1 mg
-
Ambroxol Hydrochloride IP – 30 mg
-
Guaiphenesin IP – 50 mg
-
Flavoured Syrup Base – Q.S.
The product artwork identifies the flavour as Delicious Pan Masala Flavour.
The three active ingredients have complementary pharmacological roles: bronchodilation, mucus thinning and expectoration. Levosalbutamol relaxes airway smooth muscle, Ambroxol helps reduce mucus viscosity, and Guaiphenesin helps loosen respiratory secretions.
2. Product Composition
|
Ingredient |
Strength per 5 mL |
Primary role |
|---|---|---|
|
Levosalbutamol Sulphate IP |
Equivalent to Levosalbutamol 1 mg |
Bronchodilator |
|
Ambroxol Hydrochloride IP |
30 mg |
Mucolytic |
|
Guaiphenesin IP |
50 mg |
Expectorant |
|
Flavoured Syrup Base |
Q.S. |
Vehicle/base |
Product Details
|
Specification |
Details |
|---|---|
|
Brand Name |
COFFMUL LS |
|
Generic Composition |
Levosalbutamol + Ambroxol Hydrochloride + Guaiphenesin |
|
Dosage Form |
Syrup |
|
Route |
Oral |
|
Levosalbutamol Strength |
1 mg/5 mL equivalent |
|
Ambroxol HCl Strength |
30 mg/5 mL |
|
Guaiphenesin Strength |
50 mg/5 mL |
|
Flavour |
Pan Masala, according to the artwork |
|
Therapeutic Category |
Bronchodilator + Mucolytic + Expectorant |
|
Company |
Amcare Pharmaceuticals |
|
Pack Size |
Confirm from the approved marketed pack |
3. What is COFFMUL LS Syrup?
COFFMUL LS Syrup combines three ingredients that act on different aspects of respiratory symptoms.
Levosalbutamol
Levosalbutamol is a beta-2 adrenergic agonist bronchodilator. It relaxes the smooth muscles surrounding the airways and can improve airflow when bronchospasm is present.
Ambroxol Hydrochloride
Ambroxol is a mucolytic that reduces the viscosity of respiratory mucus, helping facilitate its clearance.
Guaiphenesin
Guaiphenesin is an expectorant that helps thin mucus in the airways so that it can be coughed up more easily.
4. Active Ingredient Profile
A. Levosalbutamol Sulphate IP – Equivalent to 1 mg/5 mL
Levosalbutamol is a bronchodilator belonging to the selective beta-2 adrenergic agonist class.
Main role: Bronchodilation
It relaxes bronchial smooth muscle and can help widen narrowed airways.
Its pharmacological effects may include:
-
Relaxation of airway smooth muscle
-
Improvement in airflow during bronchospasm
-
Relief of wheezing associated with reversible airway narrowing
-
Reduction of airway resistance when bronchospasm responds to beta-2 agonists
Important precautions: Levosalbutamol may cause tremor, palpitations, a rapid heartbeat, nervousness or headache. Particular care is necessary in patients with cardiovascular disease, hyperthyroidism or diabetes.
B. Ambroxol Hydrochloride IP – 30 mg/5 mL
Ambroxol is a mucolytic medicine used in respiratory conditions associated with thick or difficult-to-clear mucus.
Main role: Mucus thinning
Ambroxol helps reduce the viscosity of mucus and supports its transport and removal from the respiratory tract.
Potential roles include:
-
Helping loosen thick respiratory secretions
-
Supporting mucus clearance
-
Making phlegm easier to expectorate
-
Helping manage selected respiratory conditions involving abnormal mucus secretion
Ambroxol does not directly act as a bronchodilator.
Precaution: Rare serious allergic and skin reactions have been reported with ambroxol. A new rash, blistering or lesions of the mouth or other mucous membranes require immediate medical assessment.
C. Guaiphenesin IP – 50 mg/5 mL
Guaiphenesin is an expectorant used to relieve chest congestion.
Main role: Expectorant / Mucus clearance
It helps thin mucus in the air passages, making secretions easier to cough up and clear.
Potential roles include:
-
Helping clear thick mucus
-
Supporting expectoration
-
Relieving symptoms associated with chest congestion
-
Helping make a productive cough more effective at removing secretions
Guaiphenesin provides symptomatic relief; it does not treat the underlying cause of respiratory illness.
5. What is COFFMUL LS Syrup Used For?
Based on the pharmacological actions of its ingredients, COFFMUL LS may be considered for selected respiratory conditions involving thick mucus and bronchospasm, provided the combination is appropriate for the patient and is used according to its approved indications.
Productive Cough
Ambroxol and Guaiphenesin support mucus thinning and clearance when thick respiratory secretions are present.
Chest Congestion
Guaiphenesin helps loosen respiratory mucus, while Ambroxol supports mucus transport and clearance.
Wheezing Associated with Bronchospasm
Levosalbutamol relaxes airway smooth muscle and may improve airflow when bronchospasm is present.
Respiratory Conditions with Difficult-to-Clear Mucus
The mucolytic and expectorant components may be relevant in selected conditions involving abnormal or thick respiratory secretions.
Important: These are the pharmacological roles of the ingredients, not confirmation of every approved indication for COFFMUL LS. The product’s exact authorised indications should be verified from its current package insert and product licence.
6. How Does COFFMUL LS Work?
COFFMUL LS combines three complementary mechanisms.
Levosalbutamol → Airway Relaxation
Bronchial smooth-muscle contraction
↓
Levosalbutamol activates beta-2 adrenergic receptors
↓
Relaxation of bronchial smooth muscle
↓
Improved airflow when bronchospasm responds to treatment
Ambroxol → Mucus Thinning
Thick respiratory mucus
↓
Ambroxol reduces mucus viscosity
↓
Respiratory secretions become easier to transport
↓
Improved mucus clearance
Guaiphenesin → Expectorant Action
Mucus in the respiratory tract
↓
Guaiphenesin helps thin secretions
↓
Mucus becomes easier to cough up
↓
Support for expectoration
Combined Action
|
Ingredient |
Principal action |
|---|---|
|
Levosalbutamol |
Bronchodilation |
|
Ambroxol |
Mucolysis |
|
Guaiphenesin |
Expectoration |
In simple terms: COFFMUL LS combines airway-relaxing activity with support for mucus thinning and clearance.
7. Product Highlights
1. Three-ingredient respiratory formulation
Contains Levosalbutamol Sulphate, Ambroxol Hydrochloride and Guaiphenesin.
2. Bronchodilator action
Levosalbutamol relaxes airway smooth muscle.
3. Mucolytic action
Ambroxol helps make thick mucus easier to clear.
4. Expectorant action
Guaiphenesin helps loosen mucus and supports expectoration.
5. Defined composition
Each 5 mL contains:
-
Levosalbutamol equivalent – 1 mg
-
Ambroxol Hydrochloride – 30 mg
-
Guaiphenesin – 50 mg
6. Flavoured syrup base
The supplied artwork identifies Delicious Pan Masala Flavour.
8. Product Specification Table
|
Specification |
Details |
|---|---|
|
Brand |
COFFMUL LS |
|
Dosage Form |
Syrup |
|
Route |
Oral |
|
Levosalbutamol |
Equivalent to 1 mg/5 mL |
|
Ambroxol Hydrochloride |
30 mg/5 mL |
|
Guaiphenesin |
50 mg/5 mL |
|
Base |
Flavoured Syrup Base |
|
Flavour |
Pan Masala, according to the artwork |
|
Therapeutic Category |
Bronchodilator + Mucolytic + Expectorant |
|
Company |
Amcare Pharmaceuticals |
|
Pack Size |
Verify from the approved marketed pack |
9. Productive Cough vs. Dry Cough
Understanding the type of cough helps guide the choice of respiratory medicine.
Productive or Wet Cough
A productive cough brings up mucus or phlegm.
Ambroxol and Guaiphenesin support mucus thinning and clearance, making their actions relevant when difficult-to-clear secretions are present.
Dry or Non-productive Cough
A dry cough produces little or no mucus.
A combination designed around mucus clearance may not be appropriate for every dry cough. The cause of the cough and the potential role of bronchodilation should be assessed clinically.
COFFMUL LS Positioning
The ingredient profile is most relevant to selected respiratory conditions involving mucus congestion and bronchospasm, rather than every type of cough.
10. Dosage and Administration
The appropriate dose and duration of COFFMUL LS must be determined from the approved product information and healthcare professional’s instructions.
The supplied artwork gives the concentration per 5 mL but does not specify a complete age-wise dosing schedule.
General administration guidance
-
Shake the syrup well before use if directed on the approved label.
-
Measure each dose accurately using an appropriate medicine-measuring device.
-
Do not use an ordinary household spoon for accurate dosing.
-
Follow the prescribed dose, frequency and duration.
-
Do not exceed the recommended dose.
-
Do not combine with another cough or respiratory medicine without checking its ingredients.
-
Seek medical advice if symptoms persist or worsen.
Do not infer a paediatric dose from the concentration alone. The approved age range and dosing schedule must be confirmed from the current COFFMUL LS product information.
11. Possible Side Effects
Side effects may arise from any of the three active ingredients.
Levosalbutamol-related effects
Possible effects include:
-
Tremor or shaking
-
Nervousness
-
Headache
-
Palpitations
-
Rapid heartbeat
-
Dizziness
-
Sleep disturbance
Beta-2 agonists can produce cardiovascular effects and tremor in susceptible patients.
Ambroxol-related effects
Possible effects include:
-
Nausea
-
Vomiting
-
Indigestion
-
Abdominal discomfort
-
Skin rash
-
Hypersensitivity reactions
Rare serious skin reactions have also been reported.
Guaiphenesin-related effects
Possible effects include:
-
Nausea
-
Vomiting
-
Headache
12. Important Safety Information
Cardiovascular Precautions
Because COFFMUL LS contains Levosalbutamol, particular caution is necessary in patients with:
-
Heart disease
-
Fast or irregular heartbeat
-
Hypertension
-
Hyperthyroidism
-
Diabetes
Levosalbutamol may cause palpitations, tremor or a rapid heartbeat.
Electrolyte Considerations
Beta-2 agonists can lower blood potassium levels in certain clinical situations, particularly with high exposure or some interacting medicines. The treating clinician should consider relevant risk factors.
Respiratory Symptoms
COFFMUL LS should not be used as a substitute for prescribed emergency treatment for acute asthma or sudden severe breathing difficulty.
Severe Skin Reactions
Stop the medicine and seek prompt medical advice if a new rash, blistering or lesions affecting the mouth or other mucous membranes occur during ambroxol treatment.
13. Precautions
Medical advice should be obtained before using COFFMUL LS in patients with:
-
Cardiovascular disease
-
Hypertension
-
Hyperthyroidism
-
Diabetes
-
Kidney or liver impairment
-
History of peptic ulcer disease
-
Known hypersensitivity to any ingredient
-
Persistent or unexplained cough
-
Chronic respiratory disease requiring ongoing treatment
The product’s approved contraindications and precautions should be confirmed from the official package insert.
14. Drug Interaction Considerations
Tell the prescribing healthcare professional about all medicines currently being taken.
Other Bronchodilators or Sympathomimetics
Other medicines with similar adrenergic activity may increase the risk of tremor, palpitations or other cardiovascular effects.
Beta-Blockers
Beta-blockers may oppose the bronchodilator action of Levosalbutamol and may be unsuitable in some patients with bronchospastic conditions.
Certain Antidepressants
Some medicines, including tricyclic antidepressants and monoamine oxidase inhibitors, may intensify the cardiovascular effects of beta-2 agonists.
Other Cough and Respiratory Medicines
Check other products carefully to avoid unnecessary duplication of bronchodilators, mucolytics or expectorants.
15. Use in Children
The supplied artwork does not state a specific approved minimum age or provide an age-wise dosing schedule.
A syrup presentation does not automatically establish suitability for every paediatric age group.
Before use in children, confirm:
-
The approved minimum age
-
The appropriate dose and frequency
-
The authorised indication
-
Relevant contraindications and precautions
Because Levosalbutamol may cause tremor and palpitations, paediatric use should be based on the approved product information and medical advice.
16. When to Consult a Doctor
Medical evaluation is recommended if the patient develops:
-
Persistent or worsening cough
-
Severe wheezing
-
Difficulty breathing
-
Chest pain
-
Rapid or irregular heartbeat
-
Severe dizziness or fainting
-
Cough with blood
-
Persistent fever
-
Severe or rapidly worsening symptoms
-
A significant rash or swelling
Sudden or severe breathing difficulty requires urgent medical attention.
17. Storage and Handling
Store COFFMUL LS according to the conditions specified on the approved product label.
General precautions include:
-
Keep the bottle tightly closed.
-
Protect from excessive heat and direct sunlight.
-
Keep out of reach of children.
-
Check the expiry date before use.
-
Do not use if the bottle or seal is damaged.
-
Follow the manufacturer’s instructions for storage after opening.
The exact storage temperature and in-use shelf life should be taken from the approved product information.
18. Packaging Information
The supplied artwork shows:
-
Amber/dark pharmaceutical bottle
-
Golden-coloured cap
-
White label with gold and blue accents
-
Respiratory/lung illustration
-
COFFMUL LS Syrup branding
-
Delicious Pan Masala Flavour statement
-
Amcare branding
The total pack volume is not clearly established by the supplied image and should be confirmed from the approved marketed carton or bottle label.